1/58
Ch. 18 Naplex 2025 book
Name | Mastery | Learn | Test | Matching | Spaced | Call with Kai |
|---|
No analytics yet
Send a link to your students to track their progress
MDRD and CKD-EPI
primary protein measured in urine to assess kidney disease.
GFR, degree of albuminuria, and the cause of CKD.
eGFR <60 mL/min/1.73 m² OR albuminuria (AER ≥30 mg/24 hr or UACR ≥30 mg/g)
must have either for longer than 3 months
G1: ≥90 + kidney damage (Stage 1);
G2: 60–89 + kidney damage (Stage 2);
G3a: 45–59;
G3b: 30–44 (Stage 3);
G4: 15–29 (Stage 4);
G5: <15 or dialysis dependent (Stage 5).
Approximately 125 mL/min/1.73 m².
What are the albuminuria categories based on ACR or AER?
A1: <30 mg/g (or mg/24 hr);
A2: 30-300 mg/g (or mg/24 hr);
A3: >300 mg/g (or mg/24 hr).
An ACE inhibitor or ARB.
(REMEMBER THESE ARE CI IF USED TOGETHER DUE TO RISK OF HYPERKALEMIA)
How do ACE inhibitors and ARBs work to delay the progression of CKD?
They cause efferent arteriolar dilation, reduce glom pressure, and decrease albuminuria
What can be expected after starting a ACEi or ARB in pts with HTN and CKD? and is this a reason to d/c therapy?
Up to a 30% increase in Scr
NO dont stop therapy!
Should an ACE inhibitor or ARB be stopped if SCr increases by ≤30% after initiation? if not, when would they be stopped?
No, this increase is expected.
d/c if the increase if >30%
What should be monitored 2-4 weeks after starting an ACE inhibitor or ARB?
What is the KDIGO-recommended first-line treatment for diabetes in patients with CKD? and what is the criteria they must meet to take it?
An SGLT2 inhibitor (farxiga, jardiance, invokana)
eGFR > /= 20
What is recommended if a patient with CKD + DM cannot use an SGLT2 inhibitor or needs additional glycemic control?
A GLP-1 receptor agonist (ozempic, victoza, trulicity)
What is finerenone? and what are the benefits of it in CKD
A nonsteroidal mineralocorticoid receptor antagonist.
It reduces CKD progression and cardiovascular risk.
In patients receiving an SGLT2 inhibitor and a maximally tolerated ACE inhibitor or ARB who have eGFR ≥25, albuminuria, and normal potassium levels.
The dose may be reduced and/or the dosing interval may be extended.
Hyperkalemia with aldosterone receptor antagonists (spironolcatone)
Which anti-infective drugs commonly require dose reduction or interval extension in CKD?
Aminoglycosides, beta-lactam antibiotics, fluconazole, quinolones (except moxifloxacin), vancomycin
Which cardiovascular drugs commonly require dose adjustment in CKD?
Enoxaparin, rivaroxaban, apixaban, dabigatran
Famotidine, metoclopramide, bisphosphonates, lithium
CrCl ≤60 mL/min.
CrCl ≤30 mL/min.
CrCl 120-125 mL/min.
Which drugs are contraindicated when CrCl <60 mL/min?
Nitrofurantoin
Which drugs are contraindicated when CrCl <50 mL/min?
Tenofovir disoproxil fumarate (TDF)-containing products and IV voriconazole.
Which drugs are contraindicated when CrCl <30 mL/min?
Tenofovir alafenamide (TAF)-containing products, NSAIDs, and dabigatran (for DVT/PE).
When is metformin contraindicated in pts with CKD?
eGFR <30 mL/min/1.73 m² (for pts who have been on it)
eGFR < /=45 (do not initiate in these pts)
Parathyroid hormone (PTH), phosphorus (phosphate, PO4), Ca, and vitamin D.
Why must hyperphosphatemia be treated? and what is treatment initially focused on?
To prevent bone disease and fractures
restricting dietary phosphate
Tenapanor (Xphozah) which is a sodium/H exchanger 3 inhibitor
Why does vitamin D deficiency occur in CKD? and what does this lead to?
The kidneys cannot activate vitamin D;
causing dietary ca absorption to decrease
What is the typical dose of aluminum hydroxide for hyperphosphatemia in the setting of CKD?
300-600 mg PO TID with meals (suspension)